This is the talk page for discussing improvements to the Antidepressant discontinuation syndrome article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 100 days ![]() |
![]() | This page is not a forum for general discussion about Antidepressant discontinuation syndrome. Any such comments may be removed or refactored. Please limit discussion to improvement of this article. You may wish to ask factual questions about Antidepressant discontinuation syndrome at the Reference desk. |
![]() | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||
|
Not sure why the infobox was removed and the high quality secondary sources in the lead were replaced by older sources, no sources, or primary sources? Doc James (talk · contribs · email) 08:20, 23 April 2020 (UTC)
It shouldn't say that this can happen with ANY antidepressant because buproprion (Wellbutrin), an NDRI, does not (outside of a few case reports). So the discontinuation side effects are linked to the serotonin actions. 73.177.232.101 (talk) 12:01, 29 May 2021 (UTC)
Voice of concern and I don’t know much about psychedelics 2601:189:4080:7990:3CB8:1854:11A:A50A (talk) 01:55, 13 December 2021 (UTC)
reference number 11, concerning duloxetine, leads to a "page not found" error instead of the FDA source 205.175.106.128 (talk) 19:43, 21 November 2022 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 9 January 2024 and 26 April 2024. Further details are available on the course page. Student editor(s): Kmcmiche (article contribs). Peer reviewers: Nicolemicha, Callalily4, Crimson Kai, Jalyn547, MPHILLI.
— Assignment last updated by Callalily4 (talk) 02:05, 18 February 2024 (UTC)